home / stock / nbix / nbix quote
Last: | $138.97 |
---|---|
Change Percent: | -0.57% |
Open: | $140.89 |
Close: | $138.97 |
High: | $144.7 |
Low: | $138.01 |
Volume: | 883,288 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$138.97 | $140.89 | $138.97 | $144.7 | $138.01 | 883,288 | 04-24-2024 |
$140.09 | $141 | $140.09 | $145 | $139.22 | 1,607,701 | 04-23-2024 |
$133.66 | $132.48 | $133.66 | $134.1798 | $131.7949 | 575,067 | 04-22-2024 |
$132 | $132.65 | $132 | $133.65 | $130.13 | 556,303 | 04-19-2024 |
$132.54 | $133.23 | $132.54 | $134.2 | $131 | 586,541 | 04-18-2024 |
$133.23 | $133.11 | $133.23 | $134.44 | $131.36 | 571,093 | 04-17-2024 |
$132.99 | $131.78 | $132.99 | $135.18 | $131.49 | 1,033,219 | 04-16-2024 |
$131.74 | $134.97 | $131.74 | $137 | $131.52 | 767,245 | 04-15-2024 |
$134.66 | $136.22 | $134.66 | $137.78 | $134.63 | 577,344 | 04-12-2024 |
$135.93 | $138.03 | $135.93 | $138.67 | $135.28 | 809,142 | 04-11-2024 |
$138.09 | $138.45 | $138.09 | $140.535 | $137.09 | 639,131 | 04-10-2024 |
$138.94 | $140.07 | $138.94 | $141.45 | $138 | 598,996 | 04-09-2024 |
$139.44 | $138.03 | $139.44 | $139.68 | $137.72 | 615,701 | 04-08-2024 |
$138.92 | $137.43 | $138.92 | $139.75 | $136.0301 | 458,610 | 04-05-2024 |
$137.61 | $138.17 | $137.61 | $140.43 | $136.74 | 1,015,263 | 04-04-2024 |
$137.59 | $137.72 | $137.59 | $140.185 | $137.36 | 614,144 | 04-03-2024 |
$137.74 | $140.61 | $137.74 | $140.61 | $136.115 | 913,872 | 04-02-2024 |
$141.38 | $137.3 | $141.38 | $141.75 | $136.845 | 995,785 | 04-01-2024 |
$137.92 | $137.83 | $137.92 | $138.72 | $135.97 | 1,245,664 | 03-29-2024 |
$137.92 | $137.83 | $137.92 | $138.72 | $135.97 | 1,245,664 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
NASDAQ Market:
Neurocrine Biosciences Inc. Website:
2024-04-24 15:15:12 ET Wells Fargo analyst issues OVERWEIGHT recommendation for NBIX on April 23, 2024 04:12PM ET. The previous analyst recommendation was Buy. NBIX was trading at $139.345 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community PR Newswire WHAT THE C@H?! provides a platform for the congenital adrenal hyperplasia (CAH) community to find educational information, share...
Neurocrine Biosciences Inc (NASDAQ:NBIX) revealed on Tuesday topline data for its Phase 2 SAVITRI study of NBI-1065845 in adult subjects with maj...